Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease

Sosei Kuma, Kiyoshi Tanaka, Takahiro Ohmine, Koichi Morisaki, Akio Kodama, Atsushi Guntani, Masaru Ishida, Jin Okazaki, Shinsuke Mii

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Although common femoral artery endarterectomy (CFE) is the standard treatment for occlusive disease of the common femoral artery (CFA), several studies have noted encouraging results for endovascular therapy in this anatomical area. Methods and Results: A retrospective multi-center study of 118 consecutive limbs from 111 symptomatic patients undergoing CFE between April 1998 and December 2014 was performed. Seventy-five CFE were performed on limbs for intermittent claudication and 43 CFE were performed for critical limb ischemia (CLI). The prevalence of perioperative complications was higher in patients with CLI than in the claudication patients. The technical success rate was 99% in all cases. The 1- and 5-year primary patency rates were 100% and 100% for claudication and 95% and 95% for CLI, respectively. The assisted-primary patency rates were 100% at both time points in both groups. Freedom from major amputation at 1 and 5 years was 100% and 100% in the claudication patients and 93% and 82% in the CLI patients, respectively. The 1- and 5-year overall survival rates were 97% and 89% in the claudication patients and 69% and 33% in the CLI patients, respectively. Conclusions: CFE is a safe, effective and durable procedure for occlusive disease of the CFA. This procedure should remain the standard treatment for this anatomical region.

Original languageEnglish
Pages (from-to)964-969
Number of pages6
JournalCirculation Journal
Volume80
Issue number4
DOIs
Publication statusPublished - Mar 25 2016

Fingerprint

Endarterectomy
Femoral Artery
Extremities
Ischemia
Intermittent Claudication
Amputation
Therapeutics
Survival Rate

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease. / Kuma, Sosei; Tanaka, Kiyoshi; Ohmine, Takahiro; Morisaki, Koichi; Kodama, Akio; Guntani, Atsushi; Ishida, Masaru; Okazaki, Jin; Mii, Shinsuke.

In: Circulation Journal, Vol. 80, No. 4, 25.03.2016, p. 964-969.

Research output: Contribution to journalArticle

Kuma, S, Tanaka, K, Ohmine, T, Morisaki, K, Kodama, A, Guntani, A, Ishida, M, Okazaki, J & Mii, S 2016, 'Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease', Circulation Journal, vol. 80, no. 4, pp. 964-969. https://doi.org/10.1253/circj.CJ-15-1177
Kuma, Sosei ; Tanaka, Kiyoshi ; Ohmine, Takahiro ; Morisaki, Koichi ; Kodama, Akio ; Guntani, Atsushi ; Ishida, Masaru ; Okazaki, Jin ; Mii, Shinsuke. / Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease. In: Circulation Journal. 2016 ; Vol. 80, No. 4. pp. 964-969.
@article{de549449eefc4a509479bc9800254248,
title = "Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease",
abstract = "Background: Although common femoral artery endarterectomy (CFE) is the standard treatment for occlusive disease of the common femoral artery (CFA), several studies have noted encouraging results for endovascular therapy in this anatomical area. Methods and Results: A retrospective multi-center study of 118 consecutive limbs from 111 symptomatic patients undergoing CFE between April 1998 and December 2014 was performed. Seventy-five CFE were performed on limbs for intermittent claudication and 43 CFE were performed for critical limb ischemia (CLI). The prevalence of perioperative complications was higher in patients with CLI than in the claudication patients. The technical success rate was 99{\%} in all cases. The 1- and 5-year primary patency rates were 100{\%} and 100{\%} for claudication and 95{\%} and 95{\%} for CLI, respectively. The assisted-primary patency rates were 100{\%} at both time points in both groups. Freedom from major amputation at 1 and 5 years was 100{\%} and 100{\%} in the claudication patients and 93{\%} and 82{\%} in the CLI patients, respectively. The 1- and 5-year overall survival rates were 97{\%} and 89{\%} in the claudication patients and 69{\%} and 33{\%} in the CLI patients, respectively. Conclusions: CFE is a safe, effective and durable procedure for occlusive disease of the CFA. This procedure should remain the standard treatment for this anatomical region.",
author = "Sosei Kuma and Kiyoshi Tanaka and Takahiro Ohmine and Koichi Morisaki and Akio Kodama and Atsushi Guntani and Masaru Ishida and Jin Okazaki and Shinsuke Mii",
year = "2016",
month = "3",
day = "25",
doi = "10.1253/circj.CJ-15-1177",
language = "English",
volume = "80",
pages = "964--969",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "4",

}

TY - JOUR

T1 - Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease

AU - Kuma, Sosei

AU - Tanaka, Kiyoshi

AU - Ohmine, Takahiro

AU - Morisaki, Koichi

AU - Kodama, Akio

AU - Guntani, Atsushi

AU - Ishida, Masaru

AU - Okazaki, Jin

AU - Mii, Shinsuke

PY - 2016/3/25

Y1 - 2016/3/25

N2 - Background: Although common femoral artery endarterectomy (CFE) is the standard treatment for occlusive disease of the common femoral artery (CFA), several studies have noted encouraging results for endovascular therapy in this anatomical area. Methods and Results: A retrospective multi-center study of 118 consecutive limbs from 111 symptomatic patients undergoing CFE between April 1998 and December 2014 was performed. Seventy-five CFE were performed on limbs for intermittent claudication and 43 CFE were performed for critical limb ischemia (CLI). The prevalence of perioperative complications was higher in patients with CLI than in the claudication patients. The technical success rate was 99% in all cases. The 1- and 5-year primary patency rates were 100% and 100% for claudication and 95% and 95% for CLI, respectively. The assisted-primary patency rates were 100% at both time points in both groups. Freedom from major amputation at 1 and 5 years was 100% and 100% in the claudication patients and 93% and 82% in the CLI patients, respectively. The 1- and 5-year overall survival rates were 97% and 89% in the claudication patients and 69% and 33% in the CLI patients, respectively. Conclusions: CFE is a safe, effective and durable procedure for occlusive disease of the CFA. This procedure should remain the standard treatment for this anatomical region.

AB - Background: Although common femoral artery endarterectomy (CFE) is the standard treatment for occlusive disease of the common femoral artery (CFA), several studies have noted encouraging results for endovascular therapy in this anatomical area. Methods and Results: A retrospective multi-center study of 118 consecutive limbs from 111 symptomatic patients undergoing CFE between April 1998 and December 2014 was performed. Seventy-five CFE were performed on limbs for intermittent claudication and 43 CFE were performed for critical limb ischemia (CLI). The prevalence of perioperative complications was higher in patients with CLI than in the claudication patients. The technical success rate was 99% in all cases. The 1- and 5-year primary patency rates were 100% and 100% for claudication and 95% and 95% for CLI, respectively. The assisted-primary patency rates were 100% at both time points in both groups. Freedom from major amputation at 1 and 5 years was 100% and 100% in the claudication patients and 93% and 82% in the CLI patients, respectively. The 1- and 5-year overall survival rates were 97% and 89% in the claudication patients and 69% and 33% in the CLI patients, respectively. Conclusions: CFE is a safe, effective and durable procedure for occlusive disease of the CFA. This procedure should remain the standard treatment for this anatomical region.

UR - http://www.scopus.com/inward/record.url?scp=84961658229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961658229&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-15-1177

DO - 10.1253/circj.CJ-15-1177

M3 - Article

C2 - 26902450

AN - SCOPUS:84961658229

VL - 80

SP - 964

EP - 969

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 4

ER -